PRISM MediaWire

PRISM MarketView

FDA Fast Track for BioXcel’s Prostate Cancer Treatment

New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - Biopharmaceutical company, BioXcel Therapeutics, Inc. (Nasdaq: BTAI), has been granted FDA Fast Track designation for BXCL701 in combination with a CPI for the treatment of patients with metastatic small...

13 February 2024

PRISM MarketView

The EV Market’s Positive Charge: PRISM Emerging EV Index Sees Green on the Screen

New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - The electric vehicle (EV) sector showcased its resilience and growth potential on Monday, as reflected in the performance of the PRISM Emerging EV Index. With carmakers steering towards more competitive p...

13 February 2024

Right on Brands Announces 10th Store Opening

DALLAS, TX, February 12, 2024 - PRISM MediaWire - Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC company and a leading developer of a diverse range of hemp-based and THCA products, announced today that it is opening it 10th licensed store at 10689 SH 205 i...

12 February 2024

PRISM MarketView

Matterport and Visiting Media Partner to Boost Hotel Marketing and Sales

New York, February 09, 2024 - PRISM MarketView - Matterport, Inc.,(Nasdaq: MTTR) a leader in digital twin technology, has established a significant partnership with Visiting Media, a leader in immersive sales enablement for the hospitality sector, to enhance hotel market...

9 February 2024

PRISM MarketView

Intelligent Bio Solutions Surges 238% on Strong Earnings

New York, February 09, 2024 - PRISM MarketView - Shares in rapid test solutions company, Intelligent Bio Solutions (Nasdaq: INBS), surged nearly 240% in intraday trading on Friday after the company reported its financial results for fiscal second quarter and six months e...

9 February 2024

PRISM MarketView

Biodexa Pharmaceuticals Reports 12-Month Survival in Glioblastoma Patients

New York, February 09, 2024 - PRISM MarketView - Biodexa Pharmaceuticals (Nasdaq: BDRX) has provided survival updates from its clinical study of MTX110 in patients with recurrent glioblastoma (“rGBM”). Currently, no standard of care is established for rGBM.

9 February 2024

PRISM MarketView

AIM ImmunoTech Tackles Post-COVID Fatigue

New York, February 09, 2024 - PRISM MarketView - AIM ImmunoTech (NYSE American: AIM) has reported positive topline results from a Phase 2 study evaluating the efficacy and safety of Ampligen® as a potential therapeutic for people with the Post-COVID condition of fatigue...

9 February 2024

PRISM MarketView

Cronos Group’s Spinach® Brand Cannabis Takes Top Spot in Canada

New York, February 08, 2024 - PRISM MediaWire - Innovative global cannabinoid company, Cronos Group’s (Nasdaq: CRON), Spinach brand has emerged as the top contender in Canada’s burgeoning cannabis market, securing the coveted position of the number one flower brand in th...

8 February 2024

PRISM MarketView

GrowGeneration Celebrates Drip Hydro’s Innovative Nutrient Line for Cannabis Cultivation

New York, February 08, 2024 - PRISM MediaWire - Drip Hydro has shaken up the cannabis cultivation industry with the introduction of its innovative powder nutrient line, designed specifically to optimize plant health and crop quality. This game-changing product marks a s...

8 February 2024

Sipp Industries Announces Distribution Agreement for Patented SinuSave® CBD Nasal Spray

COSTA MESA, CA, January 23, 2024 – PRISM MediaWire - Sipp Industries, Inc. (OTC: SIPC), a trailblazing corporation, renowned for its innovation in the manufacturing and distribution of commercial and consumer products within the cannabis industry, is pleased to announce ...

23 January 2024